Successes and reference projects
To maintain confidentiality GHB Biopharma refrains from providing names for references.
You are welcome to obtain information on completed projects upon alignment with the respective clients.
Substantial contribution to Several successful Market Authorization and New Drug Applications
Among them: Aimovig®, Voltaren Forte®, Alvesco® MDI, Omnaris®
Particular expertise in Clinical Development, Medical Affairs, and Patient Safety
with the successful conduct of > twenty Phase II-IV trials and the transition of seven products from the preclinical into the clinical stage
Management of medical benefit-risk deliverables
during a major crisis to the satisfaction of the local Health Authority, resulting in a de-escalation of relationship
Successful Design and implementation of controlled Distribution program
Integral Part to successful seed financing of innovative biotech company
Led integration of 3 separate Pharmacovigilance (PV) systems into one of the world`s largest single PV system
Spearheaded R&D delivery of innovation-focused, sustainable portfolios across Pharma and Consumer Health business models
Leadership of different transformational change initiative minimising attrition of personnel